BTCY · Biotricity Inc. · Executive Compensation
$0.66
At close · Aug 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Those conditions raise substantial doubt about its ability to continue as a going concern for a period of one year from the issuance of these condensed consolidated interim financial statements.”View the 10-Q filed Aug 19, 2026
Market Cap
$2.59M
Shares
19.91M
Volume · Aug 5
321.5K
Avg daily vol (3M)
78.21K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Jainal Bhuiyan | member of the Compensation Committee of the Board | Resigned | 2026-09-28 |
| Jainal Bhuiyan | member of the Board | Resigned | 2026-09-28 |
| Chester White | Director | Appointed | 2023-04-03 |
| Ronald McClurg | Director | Appointed | 2023-04-03 |
| David A. Rosa | Director | Appointed | 2023-04-03 |
| Waqaas Al-Siddiq | Director | Appointed | 2023-04-03 |
| Chester White | Board of Directors | Appointed | 2022-08-11 |
| Norman Betts | member of the Board of Directors | Resigned | 2022-08-11 |
| Patricia Kennedy | member of the Board of Directors | Resigned | 2022-08-11 |